Convex reports $106m net income in first quarter 2026

Convex Group reported Q1 2026 net income to common equity of $106 million, while its combined ratio improved sharply to 86.8% from 112.8% a year ago. Underwriting swung to a $121 million profit from a $117 million loss, with gross premium written up $106 million to $2.166 billion, though net written premium fell $132 million to $1.314 billion. The reported net income excludes $41 million of one-time transaction costs tied to the Onex/AIG acquisition.

Analysis

For ONEX, the key read-through is not the headline earnings beat but the direction of underwriting discipline: a sub-90 combined ratio in a specialty book typically re-rates the asset as a compounding platform rather than a cyclical earnings stream. The market should focus on whether the improved loss ratio is sustainable after catastrophe normalization; if yes, this supports higher quality-of-earnings and potentially multiple expansion over the next 2-4 quarters, especially if capital is redeployed into similarly priced specialty niches.

The second-order effect is on the competitive set in specialty insurance/reinsurance. A stronger Convex result suggests pricing is still sufficiently rational in complex lines, which is good for disciplined carriers but a warning sign for smaller underwriters that were relying on catastrophe-driven rate hardening to mask weak core margins. If acquisition-related friction is temporary, the combined entity could extract synergies faster than the street expects, but if integration distracts from renewal underwriting, the improvement could prove one-off.

The market is likely underestimating the asymmetry around capital allocation: ONEX now has a clearer case to monetize insurance cash flows or use them as a low-volatility funding source for new deals. Over the next several months, the biggest risk is that investors view this as merely a cycle-topped insurance print and ignore that specialty underwriting can stay tight longer than standard P&C when loss trends normalize slowly. Conversely, any deterioration in claims frequency or reinsurance costs would hit sentiment quickly because the stock is being asked to justify a higher-quality earnings narrative, not just growth.

Key Decisions for Investors

• Long ONEX.TO on pullbacks over the next 2-6 weeks: attractive if the market is still valuing the insurance contribution as transitory; target a re-rating on evidence of repeatable underwriting margin, with downside defined by a reversal in combined ratio toward the mid-90s.
• Pair trade: long ONEX.TO / short a lower-quality Canadian financial or holding-company name over 1-3 months, betting the market rewards visible capital efficiency and repeatable specialty earnings over conglomerate discount names with weaker cash conversion.
• Buy ONEX.TO call spreads with 3-6 month expiry: limited premium outlay to express upside from continued insurance margin strength and potential capital-allocation catalyst; risk/reward is favorable if investors start capitalizing the improved earnings base at a higher multiple.
• For a relative-value hedge, short specialty reinsurers with more catastrophe-sensitive books if pricing has already rerated them on hard-market hopes; ONEX’s cleaner underwriting print suggests discipline is now the differentiator, not just exposure.